Detection of Prethrombotic State Malignant Neoplasms, Including Pancreatic Cancer, Using Clot Waveform Analysis
Authors:   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Kobayashi Mayu , Wada Hideo ,   Department of General and Laboratory Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Fukui Shunsuke ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Shimada Yasuaki ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Nakazawa Yuuichi ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Mizutani Hiroki ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Ichikawa Yuhuko ,   Department of Central Laboratory Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Nishiura Yuuki ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Moritani Isao ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Yamanaka Yutaka ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Inou Hidekazu ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Shimaoka Motomu ,   Department of Molecular Pathobiology and Cell Adhesion Biology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan, Shimpo Hideto ,   Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan, Shiraki Katsuya ,   Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan
Published: February 2024

Background: Cancer, especially pancreatic cancer, is frequently associated with thrombosis which is one of the causes of poor outcomes; moreover hypercoagulability can be present in cancer patients. Hypercoagulability is considered to be caused by a thrombin burst. Methods: Activated Partial Tthromboplastin Time (APTT), small amount of tissue factor induced FIX activation assay (sTF/FIXa) and Thrombin Time (TT) assessment using Clot Waveform Analysis (CWA) were performed in 138 patients with malignant neoplasms, including pancreatic cancer. Results: The first derivative peak (1st DP) time (1st DPT), 1st DP height (1st DPH) and 1st DPH/1st DPT ratio were increased in a clotting-factor-FVIII-dependent manner. Thrombosis was frequently associated with pancreatic cancer and was observed in the early stage. CWA-APTT and CWA-sTF/FIXa indicated that the peak times and heights were markedly longer and higher, respectively, in cancer patients, especially pancreas cancer patients, than in patients without cancer. The 1st DPH/1st DPT ratios of CWA-sTF/FIXa were significantly high in patients with pancreas cancer (median value 1.5). CWA-TT showed that the peak times were significantly shorter in cancer patients than in healthy volunteers and that the peak heights were significantly higher in cancer than in benign pancreas diseases. The cutoff value of the 1st DPH/ 1st DPT of sTF/FIXa for cancer patients with thrombosis vs. all patients without cancer was 1.3. Conclusions: Cancer patients, including those with pancreatic cancer were frequently associated with thrombosis due to hypercoagulability caused by thrombin burst detected by CWA. A high 1st DPH/1st DPT ratio of sTF/FIXa may suggest an association with cancer or thrombosis.